The vertical platform for care delivery set up as part of the emergency response to human immunodeficiency virus (HIV) has been responsible for saving many lives in low middle income countries (LMICs). The unintended consequence of this has been the deterioration of health expenditure for general health infrastructure, especially for other disease entities such as non-communicable diseases (NCDs) including cervical cancer. As a result of the effective treatment for HIV, women live longer and therefore face an increased risk of developing cervical cancer later on in their lives. Cervical cancer is preventable in high income countries where sophisticated, well-functioning systems are in place. Although most of the LMICs in sub-Saharan Africa (sSA) have no access to these systems, most of them have benefited from the global funding for HIV care and treatment. Given new innovative cervical cancer prevention options available, this paper explores ways that LMICs countries in sub-Saaharan Africa can leverage their single disease platforms set up for HIV care and treatment for prevention of cervical cancer.